Clinical Trials Logo

Pulmonary Nodule, Solitary clinical trials

View clinical trials related to Pulmonary Nodule, Solitary.

Filter by:

NCT ID: NCT04066699 Completed - Clinical trials for Pulmonary Nodule, Solitary

Percutaneous Localization: Open-label Registry of Thoracic Surgery

PLOTS
Start date: October 10, 2019
Phase:
Study type: Observational [Patient Registry]

The objectives of this study are to evaluate intraoperative percutaneous lung lesion marking assisted by electromagnetic guided percutaneous navigation and related tools.

NCT ID: NCT04056923 Completed - Lung Cancer Clinical Trials

3D Printing for Nodule Localization

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Implementation of lung cancer screening using low-dose computed tomography has increased the rate of detection of small peripheral pulmonary nodules. However, it is hard to localize these nodules by palpation because of their small volume and long distance to the nearest pleural surface. To further clarify the confounding factors, we developed our own 3D printing localization procedure. In contrast to traditional CT-G percutaneous puncture localization, our procedure was performed in the operating room without CT scan evaluation.

NCT ID: NCT04049422 Not yet recruiting - Lung Cancer Clinical Trials

Pulmonary Nodule Cohort

liquidNodule
Start date: August 6, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to identify the clinical features of pulmonary nodules and establish a cohort to identify biomarkers for lung cancer.

NCT ID: NCT04005677 Recruiting - Clinical trials for Pulmonary Nodule, Solitary

The Early Diagnosis of Pulmonary Nodule Based on Multi-dimension Messages

Start date: July 1, 2018
Phase:
Study type: Observational

The researchers are aimed to investigate the early diagnosis of pulmonary nodule based on DNA, RNA, protein, metabolites through analyzing the serum, plasma, urine, faeces, peripheral blood mononuclear cell (PBMC), exhaled breath condensate and clinical characteristics.

NCT ID: NCT03992183 Active, not recruiting - Clinical trials for Pulmonary Nodule, Solitary

Utility of CAML as Diagnostic for Early Stage Lung Cancer

Start date: May 21, 2019
Phase:
Study type: Observational

Primary Objective Determine the prevalence of CAMLS in patients with pulmonary nodules. Secondary Objectives Determine the positive and negative predictive value of CAMLS in patients with pulmonary nodules who undergo biopsy. Model combinations of clinical factors with the presence/absence of CAMLS to refine strategies for assessment of patients with pulmonary nodules. Evaluate whether these measures result in enhanced T-cell activity and/or NK cell function and number

NCT ID: NCT03989219 Completed - Clinical trials for Pulmonary Nodule, Solitary

Methylation of cfDNA in Diagnosing and Monitoring Pulmonary Nodule

Start date: August 15, 2018
Phase:
Study type: Observational

Patients found pulmonary nodules by CT screening by will be enrolled in this study prospectively. Plasma cfDNA sequencing of these patients will be used to diagnose and monitor benign and malignant pulmonary nodules.

NCT ID: NCT03790735 Recruiting - Clinical trials for Pulmonary Nodule, Solitary

The MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules

Start date: May 3, 2018
Phase:
Study type: Observational

- The purpose of the study is the identification of the efficacy of MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules. - In this study, the investigators are going to validate the efficacy of the MDA test for diagnosing early lung cancer by comparing results of the pre-surgery MDA test with the post-surgery pathology.

NCT ID: NCT03753724 Completed - Lung Cancer Clinical Trials

IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis Study

IDEAL
Start date: August 29, 2018
Phase:
Study type: Observational

This study aims to test the use of novel CT image analysis techniques to enable a better characterisation of small pulmonary nodules. The study will incorporate solid and predominantly solid nodules of 5-15 mm scanned using a variety of scanner types, imaging protocols and patient populations. The investigators hope that the new image processing techniques will improve the accuracy of lung nodule analysis which will in turn reduce the number of unnecessary investigations for benign nodules and may increase the accuracy of the early diagnosis of lung cancer in malignant nodules. This study aims to test this novel analysis software to subsequently allow validation.

NCT ID: NCT03649906 Completed - Clinical trials for Pulmonary Nodule, Solitary

A Clinical Study of Optimized CT-guided Pulmonary Nodule Microcoil Localization Technique

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

In the early stage of the study, the CT-guided micro-coil locating method for pulmonary small nodules was optimized. This study will use a single set of target values non-randomized controlled trials to evaluate the safety and effectiveness of the optimized pre-loaded micro-coil locating method in pulmonary small nodules.

NCT ID: NCT03591445 Completed - Clinical trials for Pulmonary Nodule, Solitary

Is Bronchoscopy Necessary in the Preoperative Workup of GGO Lung Cancer?(ECTOP-1005)

Start date: November 6, 2018
Phase: N/A
Study type: Interventional

This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1005). It aims to evaluate the role of flexible bronchoscopy in the pre-operative workup of ground glass opacity featured lung cancer. All enrolled patients receive the flexible bronchoscopy examination before surgery. Investigators observe the intra-bronchial findings of bronchoscopy and the impact of these findings on established surgical plan.